OCX

OncoCyte Corporation

3.07 USD
+0.00 (+0.16%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

OncoCyte Corporation stock is down -1.29% since 30 days ago. The next earnings date is Apr 3, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 11.11% of the previous 8 February’s closed higher than January.

About OncoCyte Corporation

OncoCyte Corporation researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services.